Main > ONCOLOGY (**) > Multiple Myeloma R/R *** > Treatment > USA. J. Bispecific T-Cell Engager>B > >4 prior lines of therapy>

>proteasome inhibitor, immunomodulatory drug and anti-CD38 MAb


>4 prior lines of therapy>'s products
This section has no products